U.S. markets closed
  • S&P Futures

    4,347.75
    +4.50 (+0.10%)
     
  • Dow Futures

    33,830.00
    +32.00 (+0.09%)
     
  • Nasdaq Futures

    15,030.25
    +6.25 (+0.04%)
     
  • Russell 2000 Futures

    2,184.50
    +3.60 (+0.17%)
     
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,779.00
    +0.80 (+0.04%)
     
  • Silver

    22.80
    +0.18 (+0.81%)
     
  • EUR/USD

    1.1727
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.3240
    +0.0150 (+1.15%)
     
  • Vix

    24.36
    -1.35 (-5.25%)
     
  • GBP/USD

    1.3659
    -0.0005 (-0.04%)
     
  • USD/JPY

    109.4390
    +0.2190 (+0.20%)
     
  • BTC-USD

    42,101.68
    -765.23 (-1.79%)
     
  • CMC Crypto 200

    1,041.80
    -22.04 (-2.07%)
     
  • FTSE 100

    6,980.98
    +77.07 (+1.12%)
     
  • Nikkei 225

    29,665.42
    -174.29 (-0.58%)
     

Annovis Bio, Inc. Investors: Company Investigated by the Portnoy Law Firm

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE: ANVS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

After the market closed on July 28, 2021, Annovis reported clinical trial data for Posiphen that failed to show statistical significance in treating Alzheimer’s and Parkinson’s Disease patients relative to a placebo. On July 29, 2021 Annovis’ stock price declined by $65.94 per share, or approximately 60.25%, on this news from $109.44 per share to close at $43.50 per share.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising